Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Matrix M”

59 trials

Showing 20 of 59 results

Early research (Phase 1)Study completedNCT05135273
What this trial is testing

Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali

Who this might be right for
Malaria,Falciparum
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05380388
What this trial is testing

A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )

Who this might be right for
Plasmodium Vivax InfectionMalaria Vaccine
University of Oxford 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06549257
What this trial is testing

Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 56
Testing effectiveness (Phase 2)Study completedNCT05519839
What this trial is testing

Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine

Who this might be right for
COVID-19Influenza
Novavax 1,579
Post-approval studies (Phase 4)Not Yet RecruitingNCT07194668
What this trial is testing

R21/MM Dosing, Presentations, and Preservatives

Who this might be right for
Plasmodium Falciparum MalariaMalariaVaccine Reaction
University of Oxford 375
Post-approval studies (Phase 4)Looking for participantsNCT07038837
What this trial is testing

Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad

Who this might be right for
Malaria InfectionMalaria Vaccines
Epicentre 70,000
Large-scale testing (Phase 3)Active Not RecruitingNCT05468736
What this trial is testing

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Who this might be right for
COVID-19
Novavax 3,600
Large-scale testing (Phase 3)Study completedNCT04120194
What this trial is testing

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Who this might be right for
Influenza, Human
Novavax 2,654
Early research (Phase 1)Study completedNCT01669512
What this trial is testing

Adjuvanting Viral Vectored Malaria Vaccines With Matrix M

Who this might be right for
MalariaMatrix M
University of Oxford 23
Early research (Phase 1)Study completedNCT06507605
What this trial is testing

Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults

Who this might be right for
Prevention of Malaria Transmission and Clinical Malaria
Serum Institute of India Pvt. Ltd. 240
Testing effectiveness (Phase 2)Ended earlyNCT03658629
What this trial is testing

Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults

Who this might be right for
Influenza, Human
Novavax 1,375
Large-scale testing (Phase 3)WithdrawnNCT06482359
What this trial is testing

Lot Consistency Study of COVID-19 and Influenza Combination Vaccine

Who this might be right for
COVID-19Influenza
Novavax
Testing effectiveness (Phase 2)Looking for participantsNCT06879327
What this trial is testing

Infant Malaria Vaccine Schedule Optimization

Who this might be right for
Malaria Vaccines
PATH 1,200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07086222
What this trial is testing

Efficacy and Safety of NVX-CoV2705

Who this might be right for
COVID-19Sars-CoV-2 Infection
Novavax 6,500
Large-scale testing (Phase 3)Active Not RecruitingNCT04704830
What this trial is testing

R21/Matrix-M in African Children Against Clinical Malaria

Who this might be right for
Malaria
University of Oxford 4,800
Early research (Phase 1)Study completedNCT02370589
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

Who this might be right for
Ebola
Novavax 230
Early research (Phase 1)Active Not RecruitingNCT05385510
What this trial is testing

Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV

Who this might be right for
Malaria
University of Oxford 120
Early research (Phase 1)Study completedNCT04862416
What this trial is testing

Safety and Efficacy of R0.6C Vaccine

Who this might be right for
MalariaMalaria,Falciparum
Radboud University Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT05112848
What this trial is testing

Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)

Who this might be right for
SARS-CoV-2 Infection
Novavax 384
Large-scale testing (Phase 3)Study completedNCT04611802
What this trial is testing

Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 33,000
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation